Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Immunomedics Inc (NASDAQ:IMMU)

8.91
Delayed Data
As of Jul 24
 +0.25 / +2.89%
Today’s Change
2.02
Today|||52-Week Range
9.51
+142.78%
Year-to-Date
No recent news for Immunomedics Inc.

Today’s Trading

Previous close8.66
Today’s open8.68
Day’s range8.62 - 8.98
Volume1,281,803
Average volume (3 months)2,775,844
Market cap$982.4M
Dividend yield--
Data as of 07/24/2017

Growth & Valuation

Earnings growth (last year)-21.57%
Earnings growth (this year)-73.12%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)-42.81%
P/E ratioNM
Price/Sales68.00
Price/Book--

Competitors

 Today’s
change
Today’s
% change
--Quidel Corp-0.08-0.25%
LNTHLantheus Holdings In...+0.60+3.23%
QDELQuidel Corp+0.11+0.29%
ALRPRBAlere Inc+0.42+0.11%
Data as of 07/24/2017

Financials

Next reporting dateAugust 24, 2017
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$3.2M
Annual profit (last year)-$59.0M
Net profit margin-1,825.93%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Scientific &
Patent Officer
David M. Goldenberg
President, Chief Executive Officer &
Director
Cynthia L. Sullivan
Corporate headquarters
Morris Plains, New Jersey

Forecasts